Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Iwilfin (eflornithine)
i
Other names:
DFMO
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Norgine, US WorldMeds
Drug class:
Ornithine decarboxylase inhibitor
Related drugs:
‹
eflornithine/sulindac (1)
SBP-101 (1)
eflornithine/sulindac (1)
SBP-101 (1)
›
Associations
(1)
News
Trials
Filter by
Latest
7ms
DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma (clinicaltrials.gov)
P1/2, N=15, Recruiting, Montefiore Medical Center | Not yet recruiting --> Recruiting
7 months ago
Enrollment open
|
Iwilfin (eflornithine)
8ms
DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma (clinicaltrials.gov)
P1/2, N=15, Not yet recruiting, Montefiore Medical Center
8 months ago
New P1/2 trial
|
Iwilfin (eflornithine)
Share via
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.